UTHR United Therapeutics Corporation - Common Stock

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · unither.com

541.70USD-5.19%Mkt Cap: 23.23B $P/E: 19.403d ago

United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationa…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$64.70BUSDP/E 25.1

TAK

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

$57.06BUSD

TEVA

Teva Pharmaceutical Industries Limited Ordinary Shares

$46.10BUSDP/E 65.9

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$38.70BUSDP/E 18.3

ZTS

Zoetis Inc. Class A Common Stock

Viatris Inc. - Common Stock

$20.22BUSD

SOBI

Swedish Orphan Biovitrum AB

$14.24BUSDP/E 109.4

NBIX

Neurocrine Biosciences, Inc. - Common Stock

Elanco Animal Health Incorporated Common Stock

$11.06BUSD

RDY

Dr. Reddy's Laboratories Ltd Common Stock

Amneal Pharmaceuticals, Inc. - Class A Common Stock

$7.07BUSDP/E 42.3

ALKS

Alkermes plc - Ordinary Shares

$7.00BUSDP/E 109.9

HIMS

Hims & Hers Health, Inc. Class A Common Stock

$6.77BUSD

LNTH

Lantheus Holdings, Inc. - Common Stock

$6.53BUSDP/E 23.9

KNSA

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares

$5.83BUSDP/E 76.6

HIK

Hikma Pharmaceuticals PLC

$4.19BUSDP/E 11.9

INDV

Indivior Pharmaceuticals, Inc. - Common Stock

$4.21BUSDP/E 12.8

Key Statistics

Company

Market Cap23.23B USD

Enterprise Value20.57B USD

Revenue (TTM)3.15B USD

Gross Profit2.80B USD

Net Income (TTM)1.33B USD

Revenue/Share72.85 USD

Last Price541.70 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees1.4K

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)19.40

P/E (Forward)17.82

PEG2.22

EV/EBITDA13.75

EV/Revenue6.52

P/S7.37

P/B3.61

EPS (TTM)27.92

EPS (Forward)30.41

52W Range

408.7566% of range609.35

52W High609.35 USD

52W Low408.75 USD

Profitability

Gross Margin87.92%

Oper. Margin42.23%

EBITDA Margin47.43%

Profit Margin41.94%

ROE18.81%

ROA16.94%

Growth

Revenue Growth-1.90%

Earnings Growth13.40%

Cash Flow & Leverage

Operating CF1.56B USD

CapEx (TTM)526.00M USD

FCF Margin17.66%

FCF Yield2.40%

Net Debt-2.66B USD

Net Debt/EBITDA-1.78

Balance Sheet

Debt/Equity—

Current Ratio5.73

Quick Ratio4.89

Book Value/Sh149.97 USD

Cash/Share62.07 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split2:1

Split DateSep 23, 2009

Analyst Consensus

Rating1.9 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)644.36 USD

Upside (mean)+19.0%

Target Range321.00 USD – 728.00 USD

321.00+19.0% to mean728.00

# Analysts14

Ownership

Shares Out.42.89M

Float39.21M

Insiders2.00%

Institutions99.89%

Short Interest

Short Ratio4.9d

Short % Float7.62%

Short % Out.6.53%

Shares Short2.80M

Short (prev mo.)2.11M

Technical

SMA 50511.11 (+6.0%)

SMA 200525.34 (+3.1%)

Beta0.56

S&P 52W Chg14.58%

Avg Vol (30d)637.56K

Avg Vol (10d)1.04M

Technical Indicators

RSI (14)59.2

MACD4.0250

MACD Signal-3.9530

MACD Hist.+7.9780

BB Upper550.46 USD

BB Middle502.04 USD

BB Lower453.62 USD

BB Width19.29%

ATR (14)21.87 USD

Vol Ratio (20d)1.27x